MALMÖ, SE / ACCESS Newswire / April 8, 2025 / Ascelia Pharma (STO:ACE) - Ascelia Pharma AB (publ) (ticker:ACE), a biotech focused on improving the life of people living with rare cancer conditions, ...

A new editorial was published in , Volume 16, on April 4, 2025, titled "Deep learning-based uncertainty quantification for quality assurance in hepatobiliary imaging-based techniques." ...

A new editorial was published in Oncotarget, Volume 16, on April 4, 2025, titled “Deep learning-based uncertainty ...

The following is a summary of "Diagnostic performance of contrast-enhanced CT combined with contrast-enhanced MRI for ...

A Cleveland Clinic-led clinical trial of tolebrutinib, an investigational oral Bruton's tyrosine kinase inhibitor, a group of drugs originally developed to treat lymphomas and related blood disorders, ...

A groundbreaking 7T MRI imaging technique has uncovered hidden epilepsy lesions, making life-changing surgeries possible for patients with treatment-resistant epilepsy. Credit: SciTechDaily.com A new ...

Tolebrutinib phase 3 data published in NEJM demonstrate benefit on disability progression in multiple sclerosis. Results from the HERCULES phase 3 study showed delay in disability ...

You can create a release to package software, along with release notes and links to binary files, for other people to use. Learn more about releases in our docs.

A 63-year-old man presented with right-sided hemianopia and unsteady gait. Brain MRI revealed multiple hyperintense infarct-like lesions on diffusion-weighted images (DWI). Hyperintensity persisted in ...

Mar. 24, 2025 — A comprehensive study shows that people with fatty liver disease have almost twice the mortality rate of the general population. They have an increased risk of dying from both ...